Latest Breaking News On - Arcturus therapeutic - Page 1 : comparemela.com

Japan to start charging for mRNA vaccines in April 2024 – NaturalNews com

Japan to start charging for mRNA vaccines in April 2024 – NaturalNews com
naturalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalnews.com Daily Mail and Mail on Sunday newspapers.

Japan ministry of healthChinese virusArcturus therapeuticDrew weissman

Arcturus Therapeutics (ARCT) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research note released on Tuesday, Benzinga reports. HC Wainwright currently has a $51.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Arcturus Therapeutics’ FY2026 earnings at ($0.03) EPS and FY2027 earnings at $6.40 […]

United statesWilliam blairArcturus therapeutics holdings incCantor fitzgeraldYork mellon corpArcturus therapeutics company profileSecurities exchange commissionRoyce associatesAllspring global investments holdingsBoard of administration florida retirement systemArcturus therapeuticsFree reportArcturus therapeuticModerate buyExchange commissionFlorida retirement system

FDA orphan drug status awarded to inhaled CF therapy ARCT-032

FDA orphan drug status awarded to inhaled CF therapy ARCT-032
cysticfibrosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cysticfibrosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Joseph payneDrug administrationCystic fibrosis foundationArcturus therapeuticCystic fibrosis

Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $51.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Arcturus Therapeutics’ FY2027 earnings at $6.10 EPS. Several other research firms […]

New yorkUnited statesWilliam blairSecurities exchange commissionCantor fitzgeraldHeadlands technologiesArcturus therapeutics holdings incGreat west life assurance coArcturus therapeutics company profileArcturus therapeuticsFree reportArcturus therapeuticModerate buyExchange commissionYork state teachers retirement systemWest life assurance

From Financial Metrics To mRNA Milestones: Arcturus Therapeutics Evolving Journey (ARCT)

From Financial Metrics To mRNA Milestones: Arcturus Therapeutics Evolving Journey (ARCT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New zealandUnited kingdomBiontech comirnatySeika pharmaJapan pharmaceuticalsCf foundationDevices agencyArcturus therapeuticsOrnithine transcarbamylaseMeiji seika pharmaNew drug applicationMedical devices agencyOrphan drugRare pediatric diseaseRare pediatric disease designationArcturus therapeutic